110 results
424B3
MBRX
Moleculin Biotech Inc
16 Feb 24
Prospectus supplement
5:19pm
, or knowingly making, or causing to be made, a false statement to get a false claim paid. The majority of states also have statutes or regulations similar … of stockholders;
requiring a majority vote of the outstanding shares of common stock to amend the bylaws; and
limiting the persons who may call special
8-K
EX-99.1
hnxap
15 Feb 24
Regulation FD Disclosure
9:15am
8-K
EX-99.1
zl1gb7zwsn5z x3
24 Jan 24
Regulation FD Disclosure
8:50am
424B5
7ceqeys
22 Dec 23
Prospectus supplement for primary offering
5:00pm
8-K
EX-4.1
d8gx6f4xzena3
21 Dec 23
Moleculin Announces Pricing of $4.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market
5:17pm
8-K
EX-3.1
5txnuyzzygxekh6b
21 Dec 23
Moleculin Announces Pricing of $4.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market
5:17pm
8-K
EX-10.1
ctw0r6mhmw2
21 Dec 23
Moleculin Announces Pricing of $4.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market
5:17pm
8-K
EX-4.2
ww4o3tcxo9gw
21 Dec 23
Moleculin Announces Pricing of $4.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market
5:17pm
8-K
5gw7qi64 9k7j
21 Dec 23
Moleculin Announces Pricing of $4.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market
5:17pm
8-K
EX-99.1
bgcs5h2aawq86d
18 Dec 23
Regulation FD Disclosure
8:55am
8-K
EX-99.1
6n5nrpksgn
20 Nov 23
Regulation FD Disclosure
9:15am
8-K
EX-99.1
699us sd7
13 Nov 23
Regulation FD Disclosure
8:05am